Comparison between poor and long-term survivors with glioblastoma: Review of an Australian dataset

Asia-Pacific Journal of Clinical Oncology

Volumn 10, Issue 2, 2014, Pages 153-161

  Field, Kathryn Maree ^a   Rosenthal, Mark Andrew ^a,b   Yilmaz, Merve ^c   Tacey, Mark ^a   Drummond, Kate ^a,b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Glioblastoma; Glioma; Socio demographic; Socioeconomic; Survival

Indexed keywords

ADULT; AGE; AGE DISTRIBUTION; AGED; ARTICLE; BIRTHPLACE; BRAIN TUMOR; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; CONTROLLED STUDY; CRANIOTOMY; FEMALE; FRONTAL LOBE; FRONTAL LOBE TUMOR; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT PARTICIPATION; PRIORITY JOURNAL; PRIVATE HOSPITAL; PUBLIC HOSPITAL; RESIDENTIAL AREA; RETROSPECTIVE STUDY; SOCIAL STATUS; SURVIVAL TIME; AUSTRALIA; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL; SURVIVAL RATE;

ADULT; AGED; AUSTRALIA; BRAIN NEOPLASMS; COHORT STUDIES; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 84901593695     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/ajco.12076     Document Type: Article

References (32)

1. Stupp R, Mason WP, van den Bent MJ etal. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-996.
2. Stupp R, Hegi ME, Mason WP etal. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10: 459-466.
3. Scoccianti S, Magrini SM, Ricardi U etal. Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the central nervous system study group of Airo (Italian Association of Radiation Oncology). Neurosurgery 2010; 67: 446-458.
4. Krex D, Klink B, Hartmann C etal. Long-term survival with glioblastoma multiforme. Brain 2007; 130: 2596-2606.
5. Rosenthal MA, Drummond KJ, Dally M etal. Management of glioma in Victoria (1998-2000): retrospective cohort study. Med J Aust 2006; 184: 270-273.
6. Hegi ME, Diserens AC, Gorlia T etal. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352: 997-1003.
7. Lamborn KR, Chang SM, Prados MD. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol 2004; 6: 227-235.
8. Yu XQ, O'Connell DL, Gibberd RW etal. Assessing the impact of socio-economic status on cancer survival in New South Wales, Australia 1996-2001. Cancer Causes Control 2008; 19: 1383-1390.
9. Bentley R, Kavanagh AM, Subramanian SV etal. Area disadvantage, individual socio-economic position, and premature cancer mortality in Australia 1998 to 2000: a multilevel analysis. Cancer Causes Control 2008; 19: 183-193.
10. Berglund A, Garmo H, Robinson D etal. Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer. Eur J Cancer 2012; 48: 75-84.
11. Lapar DJ, Bhamidipati CM, Harris DA etal. Gender, race, and socioeconomic status affects outcomes after lung cancer resections in the United States. Ann Thorac Surg 2011; 92: 434-439.
12. Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol 2006; 17: 5-19.
13. Tracey ERD. What factors most influence survival and the odds of presenting with localised cancer in NSW patients? 2009. Incite; 6. [Cited 26 Mar 2012.] Available from URL: http://www.cancerinstitute.org.au/incite/issue-6/cancer-survivial-factors
14. Curry WT, Jr, Barker FG, 2nd. Racial, ethnic and socioeconomic disparities in the treatment of brain tumors. J Neurooncol 2009; 93: 25-39.
15. Tseng JH, Merchant E, Tseng MY. Effects of socioeconomic and geographic variations on survival for adult glioma in England and Wales. Surg Neurol 2006; 66: 258-263.
16. Tseng MY, Tseng JH, Merchant E. Comparison of effects of socioeconomic and geographic variations on survival for adults and children with glioma. J Neurosurg 2006; 105: 297-305.
17. Schmidt LS, Nielsen H, Schmiedel S etal. Social inequality and incidence of and survival from tumours of the central nervous system in a population-based study in Denmark, 1994-2003. Eur J Cancer 2008; 44: 2050-2057.
18. Australian Bureau of Statistics. Australian Standard Geographical Classification (ASGC), July 2011. [Cited 26 Mar 2012.] Available from URL: http://www.abs.gov.au/ausstats/abs@.nsf/mf/1216.0
19. Australian Institute of Health and Welfare. Rural, regional and remote health: indicators of health system performance. 2008. [Cited 26 Mar 2012.] Available from URL: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=6442459852
20. Jong KE, Smith DP, Yu XQ etal. Remoteness of residence and survival from cancer in New South Wales. Med J Aust 2004; 180: 618-622.
21. Baade PD, Youlden DR, Coory MD etal. Urban-rural differences in prostate cancer outcomes in Australia: what has changed? Med J Aust 2011; 194: 293-296.
22. Jong KE, Vale PJ, Armstrong BK. Rural inequalities in cancer care and outcome. Med J Aust 2005; 182: 13-14.
23. Mitchell KJ, Fritschi L, Reid A etal. Rural-urban differences in the presentation, management and survival of breast cancer in Western Australia. Breast 2006; 15: 769-776.
24. Johnson DR, Ma DJ, Buckner JC, Hammack JE. Conditional probability of long-term survival in glioblastoma: a population-based analysis. Cancer 2012; 18: 5608-5613.
25. Nieder C, Astner ST, Molls M etal. Analysis of long-term survivors of glioblastoma multiforme in a single institution with aggressive local retreatment protocol. Anticancer Res 2007; 27: 2993-2996.
26. Pink B. An Introduction to Socio-economic Indexes for Areas (SEIFA), in Statistics. Australian Bureau of Statistics, Canberra 2006; 24-32.
27. Scott JN, Rewcastle NB, Brasher PM etal. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 1999; 46: 183-188.
28. Magrini SM, Ricardi U, Santoni R etal. Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 Italian radiation oncology centers. Int J Radiat Oncol Biol Phys 2006; 65: 788-799.
29. Laws ER, Parney IF, Huang W etal. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 2003; 99: 467-473.
30. Barnholtz-Sloan JS, Maldonado JL, Williams VL etal. Racial/ethnic differences in survival among elderly patients with a primary glioblastoma. J Neurooncol 2007; 85: 171-180.
31. Cahill D, Want M, Won M etal. Extent of resection in glioblastoma - variation between molecular risk groups in RTOG-0525. Neuro Oncol 2011; 13 (Suppl 3): ST 34.
32. Nowak AK, Maujean JE, Jackson M, Knuckey N. A prospective study of surgical patterns of care for high grade glioma in the current era of multimodality therapy. J Clin Neurosci 2011; 18: 227-231.